National Center for Scientific Research Demokritos, Athens, Greece.
Acta Haematol. 2010;123(3):162-70. doi: 10.1159/000294959. Epub 2010 Mar 11.
Isochromosome of the long arm of the derivative chromosome 17, originating from the translocation t(15;17) [ider(17)(q10)t(15;17) or ider(17q)] in acute promyelocytic leukemia (APL), is a rare chromosome aberration which has been associated with a poor prognosis. In the present study, we report on 4 male APL patients with ider(17q) and review the clinical, cytogenetic and molecular characteristics of all previously reported APL patients with ider(17q) in order to clarify the clinical features and outcome of these patients. The data presented in this study demonstrated that ider(17q), which resulted in an extra RARA-PML fusion gene, was more frequent in males than females (male/female ratio of 2.12/1), was associated with a rather low initial white blood cell count and did not confer an adverse prognosis in APL patients treated with all-trans-retinoic acid and chemotherapy. The most frequent additional chromosome change to ider(17q) was trisomy 8. Ider(17q) was observed in all subtypes of the PML-RARA fusion gene, but the frequency of the bcr1 subtype was increased. Cases of overrepresentation of the RARA-PML fusion gene and ider(17q) cases may help in elucidating the role of RARA-PML in leukemogenesis.
衍生 17 号染色体长臂的等臂染色体,源自急性早幼粒细胞白血病 (APL) 的易位 t(15;17) [ider(17)(q10)t(15;17) 或 ider(17q)],是一种罕见的染色体异常,与预后不良相关。在本研究中,我们报告了 4 例男性 APL 患者具有 ider(17q),并回顾了所有先前报道的具有 ider(17q)的 APL 患者的临床、细胞遗传学和分子特征,以阐明这些患者的临床特征和结局。本研究提供的数据表明,导致额外 RARA-PML 融合基因的 ider(17q)在男性中比女性更为常见(男女比例为 2.12/1),与初始白细胞计数较低相关,并且在接受全反式维甲酸和化疗治疗的 APL 患者中并不预示不良预后。与 ider(17q)最常见的附加染色体改变是三体 8。ider(17q)见于所有 PML-RARA 融合基因亚型,但 bcr1 亚型的频率增加。RARA-PML 融合基因过度表达和 ider(17q)病例可能有助于阐明 RARA-PML 在白血病发生中的作用。